Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Prasterone | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Prasterone | hsa00030 | Pentose phosphate pathway | 5.64E-03 | 3 | P60891, P11413, P37837 | PRPS1, G6PD, TALDO1 | More | | Prasterone | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Prasterone | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Prasterone | hsa00071 | Fatty acid degradation | 3.77E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Prasterone | hsa00190 | Oxidative phosphorylation | 9.21E-05 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Prasterone | hsa00220 | Arginine biosynthesis | 3.83E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Prasterone | hsa00310 | Lysine degradation | 8.26E-04 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Prasterone | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | Prasterone | hsa00480 | Glutathione metabolism | 2.60E-05 | 5 | Q9UJ14, P11413, Q16772, P09211, P30041 | GGTL3, G6PD, GSTA3, GSTP1, PRDX6 | More | | Prasterone | hsa00500 | Starch and sucrose metabolism | 1.00E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Prasterone | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Prasterone | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Prasterone | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Prasterone | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Prasterone | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Prasterone | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Prasterone | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Prasterone | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.44E-07 | 2 | P40925, P15104 | MDH1, GLUL | More | | Prasterone | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Prasterone | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Prasterone | hsa00830 | Retinol metabolism | 3.93E-02 | 3 | P00352, Q9BPW9, O75911 | ALDH1A1, DHRS9, DHRS3 | More | | Prasterone | hsa00920 | Sulfur metabolism | 3.18E-02 | 1 | Q16762 | TST | More | | Prasterone | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.35E-05 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Prasterone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-05 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | | Prasterone | hsa00982 | Drug metabolism - cytochrome P450 | 1.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | | Prasterone | hsa00983 | Drug metabolism - other enzymes | 1.28E-04 | 5 | P04183, P32320, P05164, Q16772, P09211 | TK1, CDA, MPO, GSTA3, GSTP1 | More | | Prasterone | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Prasterone | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Prasterone | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | | Prasterone | hsa01230 | Biosynthesis of amino acids | 3.91E-02 | 3 | P51854, Q99707, P50213 | TKTL1, MTR, IDH3A | More | | Prasterone | hsa01240 | Biosynthesis of cofactors | 2.95E-02 | 2 | P13716, P14618 | ALAD, PKM2 | More | | Prasterone | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Prasterone | hsa01524 | Platinum drug resistance | 3.80E-03 | 4 | O15392, Q16772, P09211, P11388 | BIRC5, GSTA3, GSTP1, TOP2A | More | | Prasterone | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Prasterone | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Prasterone | hsa03013 | RNA transport | 4.49E-02 | 5 | P62826, Q9UBU9, P63279, P68104, Q14232 | RAN, NXF1, UBE2I, EEF1A1, EIF2B1 | More | | Prasterone | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Prasterone | hsa03020 | RNA polymerase | 6.21E-04 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Prasterone | hsa03040 | Spliceosome | 8.27E-14 | 14 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.745 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.734 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.859 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.76 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.784 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.787 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.714 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.747 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.712 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.774 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.822 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | 0.711 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.793 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Prasterone | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | Prasterone | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Prasterone | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Prasterone | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04014 | Ras signaling pathway | 1.13E-04 | 10 | P42338, P20827, P49767, P08069, Q13009, Q7LDG7, P0DP23, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, IGF1R, TIAM1, RASGRP2, CALM1, GNG5, GNG10, PLCG1 | More | | Prasterone | hsa04015 | Rap1 signaling pathway | 9.79E-05 | 14 | P20827, P49767, P08069, P06213, Q96FS4, P11215, P25116, Q8TEU7, Q13009, O00522, Q7LDG7, P42338, P08514, P19174 | EFNA1, VEGFC, IGF1R, INSR, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, KRIT1, RASGRP2, PIK3CB, ITGA2B, PLCG1 | More | | Prasterone | hsa04020 | Calcium signaling pathway | 1.53E-05 | 11 | P27987, Q08828, P21796, Q16566, P30679, O15399, P0DP23, P05141, P51828, P23634, P49767 | ITPKB, ADCY1, VDAC1, CAMK4, GNA15, GRIN2D, CALM1, SLC25A5, ADCY7, ATP2B4, VEGFC | More | | Prasterone | hsa04022 | cGMP-PKG signaling pathway | 4.38E-03 | 6 | P18848, P31751, Q08828, P51828, P05141, P0DP23 | ATF4, AKT2, ADCY1, ADCY7, SLC25A5, CALM1 | More | | Prasterone | hsa04024 | cAMP signaling pathway | 2.61E-05 | 13 | P63092, Q08828, P51828, P42338, P31751, P26678, P0DP23, P23634, P61586, Q16566, Q13370, O15399, Q13009 | GNAS, ADCY1, ADCY7, PIK3CB, AKT2, PLN, CALM1, ATP2B4, RHOA, CAMK4, PDE3B, GRIN2D, TIAM1 | More | | Prasterone | hsa04060 | Cytokine-cytokine receptor interaction | 5.34E-03 | 11 | P14784, P27930, P14778, P26842, Q06643, Q13651, P25024, Q9UBD3, P47992, P09341, P01730 | IL2RB, IL1R2, IL1R1, CD27, LTB, IL10RA, CXCR1, XCL2, XCL1, CXCL1, CD4 | More | | Prasterone | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.28E-03 | 7 | Q8NHW4, P09341, P25024, P47992, Q9UBD3, Q13651, P14784 | CCL4L2, CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RB | More | | Prasterone | hsa04062 | Chemokine signaling pathway | 2.28E-04 | 15 | P25024, P09341, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q08881, Q7LDG7, Q13009, Q8WYR1 | CXCR1, CXCL1, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ITK, RASGRP2, TIAM1, PIK3R5 | More | | Prasterone | hsa04064 | NF-kappa B signaling pathway | 4.79E-09 | 19 | P10415, Q13489, O00463, Q13546, P14778, P01584, Q04759, Q9UDY8, Q16548, P07948, P06239, Q13315, P63279, P24522, Q8NHW4, P09341, Q06643, Q9UNE0, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1R1, IL1B, PRKCQ, MALT1, BCL2A1, LYN, LCK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, LTB, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P05164 | MPO | Myeloperoxidase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P05164 | MPO | Myeloperoxidase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.821 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P05164 | MPO | Myeloperoxidase | Q04759 | PRKCQ | Protein kinase C theta type | -0.88 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P05164 | MPO | Myeloperoxidase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.758 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P05164 | MPO | Myeloperoxidase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.782 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P05164 | MPO | Myeloperoxidase | Q13315 | ATM | Serine-protein kinase ATM | -0.725 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | P05164 | MPO | Myeloperoxidase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P05164 | MPO | Myeloperoxidase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.806 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.753 |
| Prasterone | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04070 | Phosphatidylinositol signaling system | 6.93E-06 | 8 | P0DP23, P42338, O14986, Q16760, Q96PE3, P48426, Q13572, P27987 | CALM1, PIK3CB, PIP5K1B, DGKD, INPP4A, PIP4K2A, ITPK1, ITPKB | More | | Prasterone | hsa04071 | Sphingolipid signaling pathway | 7.86E-05 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Prasterone | hsa04072 | Phospholipase D signaling pathway | 1.90E-04 | 8 | P31751, P61586, O14986, Q15438, P63092, Q08828, P51828, Q16760 | AKT2, RHOA, PIP5K1B, PSCD1, GNAS, ADCY1, ADCY7, DGKD | More | | Prasterone | hsa04080 | Neuroactive ligand-receptor interaction | 1.31E-04 | 11 | P08311, P48058, Q15722, P21453, Q9H228, P43657, O00398, P21730, Q16581, P07550, P35318 | CTSG, GRIA4, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, C5AR1, C3AR1, ADRB2, ADM | More | | Prasterone | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Prasterone | hsa04114 | Oocyte meiosis | 1.78E-04 | 10 | P51812, Q02750, P0DP23, P16298, Q17RY0, Q08828, P51828, Q13362, Q14738, P08069 | RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, ADCY1, ADCY7, PPP2R5C, PPP2R5D, IGF1R | More | | Prasterone | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Prasterone | hsa04120 | Ubiquitin mediated proteolysis | 7.08E-04 | 6 | Q14145, Q13042, Q13191, P62837, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, UBE2D2, HERC1, HUWE1 | More | | Prasterone | hsa04122 | Sulfur relay system | 3.18E-02 | 1 | Q16762 | TST | More | | Prasterone | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Prasterone | hsa04140 | Autophagy - animal | 1.24E-03 | 10 | P08069, P31751, Q7L523, O75460, P22694, Q14643, P10415, Q04759, Q96GC9, Q8TEV9 | IGF1R, AKT2, RRAGA, ERN1, PRKACB, ITPR1, BCL2, PRKCQ, TMEM49, SMCR8 | More | | Prasterone | hsa04141 | Protein processing in endoplasmic reticulum | 2.78E-02 | 3 | P07384, O95487, O95816 | CAPN1, SEC24B, BAG2 | More | | Prasterone | hsa04144 | Endocytosis | 2.81E-02 | 6 | Q13191, P11142, P25024, P43250, P14784, Q9Y5X3 | CBLB, HSPA8, CXCR1, GRK6, IL2RB, SNX5 | More | | Prasterone | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | | Prasterone | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | | Prasterone | hsa04151 | PI3K-Akt signaling pathway | 1.89E-03 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Prasterone | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04210 | Apoptosis | 5.62E-04 | 10 | Q13315, P10415, O76075, P01375, Q9NR28, P24522, Q16548, P43234, P18848, Q14643 | ATM, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | | Prasterone | hsa04211 | Longevity regulating pathway | 1.96E-04 | 8 | Q12778, P31751, P08069, Q08828, P51828, P18848, Q9UEF7, Q96KQ7 | FOXO1, AKT2, IGF1R, ADCY1, ADCY7, ATF4, KL, EHMT2 | More | | Prasterone | hsa04213 | Longevity regulating pathway - multiple species | 8.35E-04 | 6 | P31751, P08069, Q9Y4H2, Q08828, P51828, Q13547 | AKT2, IGF1R, IRS2, ADCY1, ADCY7, HDAC1 | More | | Prasterone | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Prasterone | hsa04217 | Necroptosis | 2.34E-05 | 13 | P01375, P01568, P48023, Q13489, Q13546, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, CHMP2A, PPID | More | | Prasterone | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.98E-04 | 7 | Q08828, P51828, P31751, P18848, Q13362, Q14738, P0DP23 | ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Prasterone | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Prasterone | hsa04340 | Hedgehog signaling pathway | 2.61E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Prasterone | hsa04360 | Axon guidance | 1.58E-04 | 8 | P16333, P20827, O95631, P42338, P07332, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1, PTPN11 | More | | Prasterone | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Prasterone | hsa04371 | Apelin signaling pathway | 3.12E-05 | 12 | P63218, P50151, Q8WYR1, P31751, Q08828, P51828, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNG5, GNG10, PIK3R5, AKT2, ADCY1, ADCY7, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Prasterone | hsa04380 | Osteoclast differentiation | 1.88E-02 | 4 | Q9NQC7, P23458, P31751, P01584 | CYLD, JAK1, AKT2, IL1B | More | | Prasterone | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Prasterone | hsa04510 | Focal adhesion | 8.84E-03 | 4 | O14986, P61586, Q16363, P08069 | PIP5K1B, RHOA, LAMA4, IGF1R | More | | Prasterone | hsa04512 | ECM-receptor interaction | 1.62E-03 | 4 | P07359, P26012, P08514, P16070 | GP1BA, ITGB8, ITGA2B, CD44 | More | | Prasterone | hsa04514 | Cell adhesion molecules | 8.19E-03 | 3 | P16109, P56750, O00501 | SELP, CLDN17, CLDN5 | More | | Prasterone | hsa04520 | Adherens junction | 1.65E-05 | 4 | P08069, P19784, P67870, P61586 | IGF1R, CSNK2A2, CSNK2B, RHOA | More | | Prasterone | hsa04530 | Tight junction | 1.64E-06 | 8 | Q8TEU7, P63261, P16989, P56750, O00501, Q9Y478, Q92974, Q14247 | RAPGEF6, ACTG1, CSDA, CLDN17, CLDN5, PRKAB1, ARHGEF2, CTTN | More | | Prasterone | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04610 | Complement and coagulation cascades | 1.03E-03 | 3 | P25116, P09871, P0C0L4 | F2R, C1S, C4A | More | | Prasterone | hsa04611 | Platelet activation | 5.18E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Prasterone | hsa04612 | Antigen processing and presentation | 1.70E-05 | 7 | P13765, P48382, P01730, P26715, P26717, Q13241, P01732 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A | More | | Prasterone | hsa04613 | Neutrophil extracellular trap formation | 7.68E-06 | 19 | P16109, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, P21730, P08514, P07359 | SELP, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, C5AR1, ITGA2B, GP1BA | More | | Prasterone | hsa04620 | Toll-like receptor signaling pathway | 4.30E-04 | 5 | Q13546, P01568, P01584, P31751, Q8NHW4 | RIPK1, IFNA21, IL1B, AKT2, CCL4L2 | More | | Prasterone | hsa04621 | NOD-like receptor signaling pathway | 5.35E-03 | 7 | P01568, Q13489, Q13546, P01375, P59665, P59666, P12838 | IFNA21, BIRC3, RIPK1, TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Prasterone | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Prasterone | hsa04623 | Cytosolic DNA-sensing pathway | 8.89E-08 | 6 | P01584, P01568, Q13546, P25963, Q9Y535, Q8NHW4 | IL1B, IFNA21, RIPK1, NFKBIA, POLR3H, CCL4L2 | More | | Prasterone | hsa04625 | C-type lectin receptor signaling pathway | 9.86E-03 | 4 | P01584, Q9NQC7, P31751, P0DP23 | IL1B, CYLD, AKT2, CALM1 | More | | Prasterone | hsa04630 | JAK-STAT signaling pathway | 4.54E-02 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | | Prasterone | hsa04640 | Hematopoietic cell lineage | 1.15E-07 | 14 | P13612, P14778, P27930, P15144, P20023, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765 | ITGA4, IL1R1, IL1R2, ANPEP, CR2, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB | More | | Prasterone | hsa04650 | Natural killer cell mediated cytotoxicity | 6.67E-09 | 13 | P16298, P50591, P78314, P06239, O60880, P20963, Q02750, Q13241, P26718, O14931, O75015, P26717, P26715 | PPP3CB, TNFSF10, SH3BP2, LCK, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P11511 | CYP19A1 | Aromatase | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.701 | O43451 | MGAM | Maltase-glucoamylase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | O43451 | MGAM | Maltase-glucoamylase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.804 | P06239 | LCK | Tyrosine-protein kinase Lck | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.906 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P07195 | LDHB | L-lactate dehydrogenase B chain | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.706 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | O43451 | MGAM | Maltase-glucoamylase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.759 | P07195 | LDHB | L-lactate dehydrogenase B chain | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.806 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | O43451 | MGAM | Maltase-glucoamylase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P07195 | LDHB | L-lactate dehydrogenase B chain | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.816 | P06239 | LCK | Tyrosine-protein kinase Lck | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.886 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P07195 | LDHB | L-lactate dehydrogenase B chain | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.739 | P06239 | LCK | Tyrosine-protein kinase Lck | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.732 | O43451 | MGAM | Maltase-glucoamylase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.802 | O43451 | MGAM | Maltase-glucoamylase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.71 | P07195 | LDHB | L-lactate dehydrogenase B chain | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | O43451 | MGAM | Maltase-glucoamylase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.71 | P07195 | LDHB | L-lactate dehydrogenase B chain | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.779 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 |
| Prasterone | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Prasterone | hsa04658 | Th1 and Th2 cell differentiation | 1.79E-14 | 13 | Q04759, P07766, P20963, P09693, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P07195 | LDHB | L-lactate dehydrogenase B chain | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.706 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P07195 | LDHB | L-lactate dehydrogenase B chain | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.935 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P07195 | LDHB | L-lactate dehydrogenase B chain | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.778 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P07195 | LDHB | L-lactate dehydrogenase B chain | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.786 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P07195 | LDHB | L-lactate dehydrogenase B chain | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.733 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 |
| Prasterone | hsa04659 | Th17 cell differentiation | 4.69E-15 | 19 | P25963, Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P13765, P14778, P40189, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL6ST, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.728 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P07195 | LDHB | L-lactate dehydrogenase B chain | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.733 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | O43451 | MGAM | Maltase-glucoamylase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.924 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | O43451 | MGAM | Maltase-glucoamylase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.799 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P07195 | LDHB | L-lactate dehydrogenase B chain | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.786 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | O43451 | MGAM | Maltase-glucoamylase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.771 | P07195 | LDHB | L-lactate dehydrogenase B chain | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.778 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.769 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.721 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P07195 | LDHB | L-lactate dehydrogenase B chain | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.935 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P07195 | LDHB | L-lactate dehydrogenase B chain | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.706 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Prasterone | hsa04660 | T cell receptor signaling pathway | 5.20E-09 | 14 | Q9UDY8, Q04759, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | MALT1, PRKCQ, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | O43451 | MGAM | Maltase-glucoamylase | Q04759 | PRKCQ | Protein kinase C theta type | -0.777 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P07195 | LDHB | L-lactate dehydrogenase B chain | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P07195 | LDHB | L-lactate dehydrogenase B chain | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.817 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.73 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | O43451 | MGAM | Maltase-glucoamylase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.79 | P07195 | LDHB | L-lactate dehydrogenase B chain | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.706 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | O43451 | MGAM | Maltase-glucoamylase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.755 | P07195 | LDHB | L-lactate dehydrogenase B chain | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.935 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | O43451 | MGAM | Maltase-glucoamylase | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | O43451 | MGAM | Maltase-glucoamylase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.764 | P07195 | LDHB | L-lactate dehydrogenase B chain | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.792 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | O43451 | MGAM | Maltase-glucoamylase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.712 | P07195 | LDHB | L-lactate dehydrogenase B chain | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.761 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | O43451 | MGAM | Maltase-glucoamylase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.748 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | O43451 | MGAM | Maltase-glucoamylase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.871 | O43451 | MGAM | Maltase-glucoamylase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 |
| Prasterone | hsa04662 | B cell receptor signaling pathway | 1.21E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Prasterone | hsa04664 | Fc epsilon RI signaling pathway | 8.33E-05 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Prasterone | hsa04666 | Fc gamma R-mediated phagocytosis | 3.01E-03 | 4 | P07948, P42338, P23528, P14598 | LYN, PIK3CB, CFL1, NCF1 | More | | Prasterone | hsa04672 | Intestinal immune network for IgA production | 4.27E-02 | 2 | P13765, P13612 | HLA-DOB, ITGA4 | More | | Prasterone | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Prasterone | hsa04713 | Circadian entrainment | 1.28E-04 | 8 | O15399, P0DP23, P62873, P63218, P50151, Q08828, P51828, P63092 | GRIN2D, CALM1, GNB1, GNG5, GNG10, ADCY1, ADCY7, GNAS | More | | Prasterone | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | | Prasterone | hsa04720 | Long-term potentiation | 7.98E-05 | 8 | Q16566, P16298, P0DP23, P51812, P18848, O15399, Q08828, Q02750 | CAMK4, PPP3CB, CALM1, RPS6KA3, ATF4, GRIN2D, ADCY1, MAP2K1 | More | | Prasterone | hsa04721 | Synaptic vesicle cycle | 9.45E-04 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Prasterone | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Prasterone | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Prasterone | hsa04724 | Glutamatergic synapse | 2.22E-05 | 7 | O15399, P43003, P63092, P62873, P63218, P50151, P15104 | GRIN2D, SLC1A3, GNAS, GNB1, GNG5, GNG10, GLUL | More | | Prasterone | hsa04725 | Cholinergic synapse | 4.78E-05 | 11 | Q08828, P51828, P22694, Q14643, P63218, P50151, P18848, Q16566, P42338, P31751, P10415 | ADCY1, ADCY7, PRKACB, ITPR1, GNG5, GNG10, ATF4, CAMK4, PIK3CB, AKT2, BCL2 | More | | Prasterone | hsa04726 | Serotonergic synapse | 9.72E-04 | 6 | P63092, P62873, P63218, P50151, P33260, P09917 | GNAS, GNB1, GNG5, GNG10, CYP2C18, ALOX5 | More | | Prasterone | hsa04727 | GABAergic synapse | 4.42E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Prasterone | hsa04728 | Dopaminergic synapse | 1.05E-03 | 8 | P63218, P50151, P31751, P18848, Q13362, Q14738, P0DP23, O00327 | GNG5, GNG10, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1, ARNTL | More | | Prasterone | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.86E-03 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | | Prasterone | hsa04810 | Regulation of actin cytoskeleton | 2.58E-02 | 3 | Q15746, P08514, P25116 | MYLK, ITGA2B, F2R | More | | Prasterone | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Prasterone | hsa04911 | Insulin secretion | 2.40E-02 | 3 | Q08828, P51828, P18848 | ADCY1, ADCY7, ATF4 | More | | Prasterone | hsa04912 | GnRH signaling pathway | 1.39E-02 | 4 | Q08828, P51828, P18848, P0DP23 | ADCY1, ADCY7, ATF4, CALM1 | More | | Prasterone | hsa04913 | Ovarian steroidogenesis | 8.40E-04 | 2 | P06213, P08069 | INSR, IGF1R | More | | Prasterone | hsa04914 | Progesterone-mediated oocyte maturation | 9.67E-04 | 7 | P08069, Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | IGF1R, CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | | Prasterone | hsa04915 | Estrogen signaling pathway | 2.83E-03 | 9 | P14780, P22694, P18848, Q08828, P51828, P31751, Q14643, P0DP23, P10415 | MMP9, PRKACB, ATF4, ADCY1, ADCY7, AKT2, ITPR1, CALM1, BCL2 | More | | Prasterone | hsa04916 | Melanogenesis | 2.40E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | | Prasterone | hsa04918 | Thyroid hormone synthesis | 3.50E-02 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Prasterone | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Prasterone | hsa04920 | Adipocytokine signaling pathway | 2.62E-03 | 3 | Q06124, Q9Y478, Q96RR4 | PTPN11, PRKAB1, CAMKK2 | More | | Prasterone | hsa04922 | Glucagon signaling pathway | 7.57E-03 | 5 | P14618, P22694, P06737, Q12778, Q14643 | PKM2, PRKACB, PYGL, FOXO1, ITPR1 | More | | Prasterone | hsa04923 | Regulation of lipolysis in adipocytes | 7.59E-04 | 4 | Q08828, P51828, P06213, P31751 | ADCY1, ADCY7, INSR, AKT2 | More | | Prasterone | hsa04924 | Renin secretion | 8.19E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Prasterone | hsa04925 | Aldosterone synthesis and secretion | 7.24E-04 | 6 | P18848, Q08828, P51828, P0DP23, Q16566, P23634 | ATF4, ADCY1, ADCY7, CALM1, CAMK4, ATP2B4 | More | | Prasterone | hsa04926 | Relaxin signaling pathway | 3.95E-04 | 9 | P31751, P42338, P63218, P50151, P18848, P49767, Q08828, P51828, P30679 | AKT2, PIK3CB, GNG5, GNG10, ATF4, VEGFC, ADCY1, ADCY7, GNA15 | More | | Prasterone | hsa04927 | Cortisol synthesis and secretion | 5.17E-04 | 5 | Q14643, P18848, Q08828, P51828, P22694 | ITPR1, ATF4, ADCY1, ADCY7, PRKACB | More | | Prasterone | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.33E-03 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | | Prasterone | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Prasterone | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Prasterone | hsa04932 | Non-alcoholic fatty liver disease | 5.87E-04 | 8 | P31751, P01375, P49841, P18848, P48023, O75460, P01584, O95298 | AKT2, TNF, GSK3B, ATF4, FASLG, ERN1, IL1B, NDUFC2 | More | | Prasterone | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.11E-03 | 6 | P84022, Q13485, P10415, P42338, P49767, P19174 | SMAD3, SMAD4, BCL2, PIK3CB, VEGFC, PLCG1 | More | | Prasterone | hsa04934 | Cushing syndrome | 4.54E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Prasterone | hsa04935 | Growth hormone synthesis, secretion and action | 1.88E-02 | 4 | Q08828, P51828, P18848, P31751 | ADCY1, ADCY7, ATF4, AKT2 | More | | Prasterone | hsa04940 | Type I diabetes mellitus | 6.87E-04 | 2 | P48023, P01375 | FASLG, TNF | More | | Prasterone | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | | Prasterone | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Prasterone | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Prasterone | hsa04970 | Salivary secretion | 1.59E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | | Prasterone | hsa04971 | Gastric acid secretion | 2.54E-03 | 4 | Q08828, P51828, P15311, P0DP23 | ADCY1, ADCY7, VIL2, CALM1 | More | | Prasterone | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | | Prasterone | hsa04975 | Fat digestion and absorption | 9.50E-04 | 1 | O14494 | PLPP1 | More | | Prasterone | hsa04976 | Bile secretion | 7.23E-04 | 5 | Q08828, P51828, P22694, P08183, Q14032 | ADCY1, ADCY7, PRKACB, ABCB1, BAAT | More | | Prasterone | hsa05010 | Alzheimer disease | 4.94E-03 | 9 | O95298, Q00535, O75460, P0DP23, P01584, P18848, P31751, P05141, P28070 | NDUFC2, CDK5, ERN1, CALM1, IL1B, ATF4, AKT2, SLC25A5, PSMB4 | More | | Prasterone | hsa05016 | Huntington disease | 2.24E-02 | 7 | O95298, P24928, P30876, P62487, P05141, O75460, P28070 | NDUFC2, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4 | More | | Prasterone | hsa05017 | Spinocerebellar ataxia | 5.81E-05 | 9 | Q92915, O75460, Q8TB72, O15399, P42338, P31751, P28070, P05141, P21796 | FGF14, ERN1, PUM2, GRIN2D, PIK3CB, AKT2, PSMB4, SLC25A5, VDAC1 | More | | Prasterone | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.67E-02 | 9 | O95298, Q8TEV9, O75460, P18848, P05141, Q00535, P01584, P0DP23, P28070 | NDUFC2, SMCR8, ERN1, ATF4, SLC25A5, CDK5, IL1B, CALM1, PSMB4 | More | | Prasterone | hsa05032 | Morphine addiction | 9.04E-05 | 5 | P62873, P48169, P78334, P63092, P32298 | GNB1, GABRA4, GABRE, GNAS, GRK4 | More | | Prasterone | hsa05034 | Alcoholism | 6.66E-06 | 12 | O15399, Q16566, Q13547, P0DP23, P63218, P50151, Q93077, P58876, P62807, Q16778, O60814, P68431 | GRIN2D, CAMK4, HDAC1, CALM1, GNG5, GNG10, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Prasterone | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.76E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Prasterone | hsa05130 | Pathogenic Escherichia coli infection | 2.02E-04 | 8 | Q14247, P56750, O00501, Q92974, P63261, P25116, Q06124, O95487 | CTTN, CLDN17, CLDN5, ARHGEF2, ACTG1, F2R, PTPN11, SEC24B | More | | Prasterone | hsa05132 | Salmonella infection | 5.76E-04 | 7 | P25963, Q13546, Q13489, P10415, Q9BQS8, O60282, P68371 | NFKBIA, RIPK1, BIRC3, BCL2, FYCO1, KIF5C, TUBB2C | More | | Prasterone | hsa05133 | Pertussis | 1.86E-03 | 3 | P09871, P0C0L4, Q02556 | C1S, C4A, IRF8 | More | | Prasterone | hsa05135 | Yersinia infection | 1.52E-02 | 6 | P13612, P06239, Q16539, P49841, P01730, P01732 | ITGA4, LCK, MAPK14, GSK3B, CD4, CD8A | More | | Prasterone | hsa05140 | Leishmaniasis | 2.18E-04 | 6 | P14598, P42224, O60603, P25963, P29350, Q15080 | NCF1, STAT1, TLR2, NFKBIA, PTPN6, NCF4 | More | | Prasterone | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | Prasterone | hsa05143 | African trypanosomiasis | 4.76E-05 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Prasterone | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Prasterone | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Prasterone | hsa05146 | Amoebiasis | 6.00E-04 | 6 | P09341, P14778, P27930, P05089, P12814, P08311 | CXCL1, IL1R1, IL1R2, ARG1, ACTN1, CTSG | More | | Prasterone | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Prasterone | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Prasterone | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Prasterone | hsa05163 | Human cytomegalovirus infection | 1.51E-06 | 17 | P31751, P42338, P62873, P63218, P50151, P0DP23, P61586, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651, P18848, P63092, P30101, P61769 | AKT2, PIK3CB, GNB1, GNG5, GNG10, CALM1, RHOA, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA, ATF4, GNAS, PDIA3, B2M | More | | Prasterone | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Prasterone | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Prasterone | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.44E-03 | 9 | P42338, P62879, P63218, P50151, P16298, Q02750, P07948, P0DP23, P0CG47 | PIK3CB, GNB2, GNG5, GNG10, PPP3CB, MAP2K1, LYN, CALM1, UBB | More | | Prasterone | hsa05168 | Herpes simplex virus 1 infection | 1.38E-04 | 15 | P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, Q13489, P42338, Q13398, Q9HCX3, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PIK3CB, ZNF211, ZNF304, ZNF85, ZNF140, ZNF189, ZNF212 | More | | Prasterone | hsa05169 | Epstein-Barr virus infection | 5.02E-04 | 12 | P20023, P13765, P01106, Q13547, Q92769, O00463, P07948, Q13761, P24522, P07766, P09693, P20963 | CR2, HLA-DOB, MYC, HDAC1, HDAC2, TRAF5, LYN, RUNX3, GADD45A, CD3E, CD3G, CD247 | More | | Prasterone | hsa05170 | Human immunodeficiency virus 1 infection | 7.38E-04 | 11 | P42338, Q02750, P62879, P63218, P50151, P16298, P0DP23, Q05397, P30101, P23528, P20333 | PIK3CB, MAP2K1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PDIA3, CFL1, TNFRSF1B | More | | Prasterone | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | | Prasterone | hsa05200 | Pathways in cancer | 1.31E-03 | 21 | Q13751, P42338, P08238, P42224, P19174, P43246, P84022, Q13485, Q13547, P14923, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 |
| Prasterone | hsa05202 | Transcriptional misregulation in cancer | 1.38E-05 | 17 | Q12778, Q15532, Q13315, P14780, P27930, Q15744, Q16548, P11215, O15550, P08069, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, UTX, IGF1R, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | | Prasterone | hsa05203 | Viral carcinogenesis | 2.10E-04 | 8 | Q12933, P42229, Q13547, Q15283, P58876, P62807, Q16778, O60814 | TRAF2, STAT5A, HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Prasterone | hsa05204 | Chemical carcinogenesis | 2.55E-05 | 5 | Q16772, P09211, P78417, P11712, P33260 | GSTA3, GSTP1, GSTO1, CYP2C9, CYP2C18 | More | | Prasterone | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Prasterone | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Prasterone | hsa05212 | Pancreatic cancer | 1.59E-05 | 8 | P42338, P31751, Q15311, P23458, P42224, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, STAT1, SMAD3, SMAD4, GADD45B | More | | Prasterone | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Prasterone | hsa05214 | Glioma | 1.25E-04 | 5 | P08069, P0DP23, Q16566, P42338, O75293 | IGF1R, CALM1, CAMK4, PIK3CB, GADD45B | More | | Prasterone | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa05217 | Basal cell carcinoma | 2.83E-02 | 3 | Q13635, Q9UJU2, P24522 | PTCH1, LEF1, GADD45A | More | | Prasterone | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | | Prasterone | hsa05220 | Chronic myeloid leukemia | 1.44E-03 | 6 | Q13547, Q13485, P25963, P84022, P42338, O75293 | HDAC1, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Prasterone | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Prasterone | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | | Prasterone | hsa05226 | Gastric cancer | 4.33E-03 | 5 | Q02750, O15169, P84022, Q13485, P10415 | MAP2K1, AXIN1, SMAD3, SMAD4, BCL2 | More | | Prasterone | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Prasterone | hsa05231 | Choline metabolism in cancer | 3.38E-02 | 3 | P31751, Q16760, O14986 | AKT2, DGKD, PIP5K1B | More | | Prasterone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.30E-05 | 9 | P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Prasterone | hsa05321 | Inflammatory bowel disease | 1.03E-05 | 6 | O60603, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Prasterone | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Prasterone | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Prasterone | hsa05330 | Allograft rejection | 1.51E-03 | 2 | P48023, P01375 | FASLG, TNF | More | | Prasterone | hsa05332 | Graft-versus-host disease | 5.29E-09 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Prasterone | hsa05340 | Primary immunodeficiency | 2.04E-03 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Prasterone | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Prasterone | hsa05415 | Diabetic cardiomyopathy | 7.96E-03 | 7 | P17252, P14598, Q15080, Q16718, O14521, P04406, P11413 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH, G6PD | More | | Prasterone | hsa05418 | Fluid shear stress and atherosclerosis | 3.73E-02 | 4 | P42338, P14598, P0DP23, P08238 | PIK3CB, NCF1, CALM1, HSP90AB1 | More | | |